The utilization of MLPA is presently regarded as a labor-efficient primary method for detecting deletions and duplications of single or multiple exons in the DMD gene, as approximately 70% of dystrophinopathy patients exhibit such genetic alterations [2]. Here, DMD is linked to neuromuscular disease caused by qualitative or quantitative defects of dystrophin.